ArticleOncotarget2016

Inhibition of HAX-1 by miR-125a reverses cisplatin resistance in laryngeal cancer stem cells.

Jiajia Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.